		<div class="wpcnt">
			<div class="wpa">
				<span class="wpa-about">Advertisements</span>
				<div class="u top_amp">
							<amp-ad width="300" height="265"
		 type="pubmine"
		 data-siteid="111265417"
		 data-section="1">
		</amp-ad>
				</div>
			</div>
		</div><p>Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing capacity continue at pace.</p>
<p>The alliance, which was forged by Germany, France, Italy and the Netherlands to speed up production of a vaccine, is set to take delivery of the material being tested by the University of Oxford by the end of 2020.</p>
<p>The agreement with AstraZeneca also aims to make the vaccine available to other European countries wishing to take part.</p>
<p>The cost is expected to be offset by funding from the governments involved.</p>
<p>AstraZeneca CEO Pascal Soriot said: “<i>This agreement will ensure that hundreds of millions of Europeans have access to Oxford University’s vaccine following approval.</i></p>
<p>“<i>With our European supply chain due to begin production soon, we hope to make the vaccine available widely and rapidly.</i>”</p>
<blockquote class="twitter-tweet" data-width="550" data-dnt="true">
<p lang="en" dir="ltr">We have reached an agreement with the Inclusive Vaccines Alliance to supply up to 400 million doses of <a href="https://twitter.com/UniofOxford?ref_src=twsrc%5Etfw">@UniofOxford</a>’s potential <a href="https://twitter.com/hashtag/COVID19?src=hash&;ref_src=twsrc%5Etfw">#COVID19</a> vaccine to Europe at no profit <a href="https://t.co/eVXJs66S3b">https://t.co/eVXJs66S3b</a> <a href="https://t.co/yBRr5GRC56">pic.twitter.com/yBRr5GRC56</a></p>
<p>&mdash; AstraZeneca (@AstraZeneca) <a href="https://twitter.com/AstraZeneca/status/1271792649855545344?ref_src=twsrc%5Etfw">June 13, 2020</a></p></blockquote>
<p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p>
<p>The agreement is the latest in a series to make the vaccine – even though it is not certain it will work. But the need for a vaccine is so great that the scaling up of manufacturing continues despite the risk.</p>
<p>The Anglo-Swedish company recently completed similar agreements with the UK, the US, the Coalition for Epidemic Preparedness Innovations, and Gavi, the Vaccine Alliance, for 700 million doses.</p>
<p>A licence also has been agreed with the Serum Institute of India for another billion doses.</p>
<p>The vaccine was developed by Oxford University’s Jenner Institute, working with the Oxford Vaccine Group.</p>
<p>Testing of the experimental Covid-19 vaccine began in healthy volunteers in Britain in April with more than 1,000 people aged 18 to 55. Another round with 10,000 volunteers began last month.</p>
<p>Other companies, including Moderna and Sanofi, are racing to develop and produce a vaccine against the new coronavirus, a step experts say will be crucial to allowing countries to ease their lockdowns and restrictions on public life.</p>
			<div style="padding-bottom:15px;" class="wordads-tag" data-slot-type="belowpost">
				<div id="atatags-dynamic-belowpost-68ec9f5d1739e">
					<script type="text/javascript">
						window.getAdSnippetCallback = function () {
							if ( false === ( window.isWatlV1 ?? false ) ) {
								// Use Aditude scripts.
								window.tudeMappings = window.tudeMappings || [];
								window.tudeMappings.push( {
									divId: 'atatags-dynamic-belowpost-68ec9f5d1739e',
									format: 'belowpost',
								} );
							}
						}

						if ( document.readyState === 'loading' ) {
							document.addEventListener( 'DOMContentLoaded', window.getAdSnippetCallback );
						} else {
							window.getAdSnippetCallback();
						}
					</script>
				</div>
			</div>
Discover more from London Glossy Post
Subscribe to get the latest posts sent to your email.
